AMPH CIK: 1297184

Amphastar Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
98.0
FY22:
89.2
FY23:
184
FY24:
213
FY25:
156
Change from FY21 to FY25
millions USD
FY21:
−28.7
FY22:
−32.8
FY23:
−649
FY24:
−125
FY25:
−70.3
Change from FY21 to FY25
millions USD
FY21:
−37.0
FY22:
−26.4
FY23:
454
FY24:
−81.0
FY25:
−67.4
millions USD
FY21:
32.1
FY22:
29.7
FY23:
−11.8
FY24:
7.31
FY25:
18.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
70.5
FY22:
65.1
FY23:
145
FY24:
172
FY25:
121

All amounts in millions USD Data source:SEC EDGAR